GeneFerm Biotechnology Co

GeneFerm Biotechnology Co Current Liabilities

The Current Liabilities of GeneFerm Biotechnology Co (1796.TWO) as of Oct 16, 2026 is 16.14 M TWD. In the previous year, Current Liabilities was 89.07 M TWD — a change of -81.88% (lower).

Current Liabilities

16.14 MTWD

YoY

-81.88%

Last updated:

Current Liabilities of GeneFerm Biotechnology Co is 2025 16.14 M TWD. Current Liabilities of GeneFerm Biotechnology Co was 2024 89.07 M TWD. It decreases by -81.88% lower compared to the previous year.

The GeneFerm Biotechnology Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
58.86 M TWD
Jan 1, 2019
94.02 M TWD
Jan 1, 2020
147.64 M TWD
Jan 1, 2021
975.42 M TWD
Jan 1, 2022
263.57 M TWD
Jan 1, 2023
253.77 M TWD
Jan 1, 2024
89.07 M TWD
Jan 1, 2025
16.14 M TWD
The GeneFerm Biotechnology Co Current Liabilities history
YEARCurrent LiabilitiesYoY
16.14 MTWD-81.88%
89.07 MTWD-64.90%
253.77 MTWD-3.72%
263.57 MTWD-72.98%
975.42 MTWD+560.68%
147.64 MTWD+57.03%
94.02 MTWD+59.74%
58.86 MTWD+26.86%
46.39 MTWD-56.70%
107.15 MTWD+59.65%
67.11 MTWD-9.06%
73.80 MTWD+35.46%
54.48 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GeneFerm Biotechnology Co Stock analysis

What does GeneFerm Biotechnology Co do? GeneFerm Biotechnology Co Ltd is a company based in Tainan, Taiwan, operating within the Consumer Staples sector and the Consumer products industry. It went public on July 26, 2016, with the ticker symbol 1796.TWO and ISIN TW0001796001. The company focuses on the manufacture and sale of health food and dietary supplements. Its product portfolio includes fermented products, medicinal mushrooms, lactic acid bacteria products, and fruit and vegetable fermented concentrates. GeneFerm also offers related manufacturing services, as well as health food design, research, and development services. The company's headquarters are located in Tainan, Taiwan, and it maintains a website at https://www.geneferm.com/. As a publicly traded entity, GeneFerm Biotechnology Co Ltd is listed on the Taiwan Stock Exchange, providing investors with access to its financial performance and corporate activities. The company's operations are centered around the development and production of health-focused food and supplement products, emphasizing natural and fermented ingredients. Its services extend beyond product manufacturing to include design, R&D, and manufacturing support for health food solutions. The firm has been active in the market since its IPO in 2016, contributing to the consumer staples sector with its specialized health food offerings. GeneFerm Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneFerm Biotechnology Co stock

Current Liabilities of GeneFerm Biotechnology Co is 16.14 M TWD in 2025.

Current Liabilities of GeneFerm Biotechnology Co changed from 89.07 M TWD to 16.14 M TWD, representing a -81.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities GeneFerm Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's GeneFerm Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — GeneFerm Biotechnology Co

All Key Metrics — GeneFerm Biotechnology Co